Latest Asx Listing Rules News

Aspen Group has successfully raised $70.18 million through an institutional placement, aiming to reduce debt and pursue new growth opportunities. A Security Purchase Plan is also underway for eligible investors.

Norwood Systems has successfully completed a $500,000 oversubscribed placement, positioning itself for accelerated growth and strategic debt reduction. The funds will support market expansion, product innovation, and operational improvements.

Heavy Minerals Limited attributes its recent share price jump to media coverage about its upcoming Port Gregory Pre-Feasibility Study and confirms compliance with ASX disclosure rules.

Marquee Resources has successfully raised nearly $600,000 through an oversubscribed share placement, signaling strong investor confidence ahead of a key drilling campaign at its Mt Clement project.

Emu NL has raised $300,000 through a placement of 17.6 million shares priced at 1.7 cents each, aiming to fund its exploration projects and support working capital needs.

Mayne Pharma has addressed a sharp share price decline following the public release of an FDA Untitled Letter, confirming no undisclosed material information and reaffirming compliance with ASX rules.

Peak Rare Earths Limited has voluntarily suspended trading of its shares pending a significant announcement on potential corporate and capital raising transactions expected by 16 May 2025.

Nimy Resources has clarified that no undisclosed information explains its recent share price jump, pointing instead to ongoing drilling and positive media coverage about a gallium discovery.

Rox Resources has successfully raised $36 million through the first tranche of its $40 million placement, with the second tranche pending shareholder approval. This capital injection aims to support its gold exploration projects in Western Australia.

Burgundy Diamond Mines has released its amended 2024 Mineral Resources and Ore Reserves report for the Ekati diamond mine, showing minor depletion due to ongoing mining activities. The update confirms continued compliance with industry standards and robust governance.

Holista Colltech Limited has responded to an ASX price query regarding recent unusual trading activity, confirming no undisclosed material information exists to explain the surge.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.